Work

Chemotherapy free ponatinib + asciminib achieves optimal disease controlpreallohsct in advanced – CML

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417010057
Cites:
Cited by: 1
Related to: